Corporate greed and medical complicity fueled a $250,000 drug
Internal medicine and pulmonary physician Bharat Desai discusses his article "How Acthar Gel became a $250,000 drug." Bharat shares the shocking moment he realized an obsolete pituitary extract from 1952 was being sold for the price of a house. He explains how pharmaceutical companies exploited regulatory loopholes to reclassify a…























